Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 7, 2000, Pages 1827-1832

  Tanaka, Kazumi ^a   Yamada, Jun ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIG; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTERIOR CHAMBER; ANTIGENS, CD4; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT C3; CORNEA; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIGS; IMMUNOGLOBULIN MU-CHAINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034122208     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Auchincloss H. Xenogencic transplantation: a review. Transplantation. 1988;46:1-20.
2. Platt JL. Xenotransplantation: recent progress and current perspective. Curr Opin Immunol. 1996;8:721-728.
3. Auchincloss H, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol. 1998;16:433-470.
4. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today. 1990;11:450-457.
5. Soares M, Lu X, Havaux X, et al. In vivo IgM depletion by anti-μ, monoclonal antibody therapy: the role of IgM in hyperacute vascular rejection of discordant xenografts. Transplantation. 1994; 57:1003-1009.
6. Schaapherder AFM, Daha MR, TeBulte MTJW, van der Woude FJ, Gooszen HG. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation. 1994;57:1376-1382.
7. Kroshus TJ, Bolman RM III, Dalmasso AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation. 1996;62:5-12
8. Candinas D, Belliveau S, Koyamada N, et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation. 1996;62:1920-1927.
9. Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol. 1997;158:5658-5667.
10. Goslings WRO, Prodeus AP, Streilein JW, et al A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci. 1998;39:989-995.
11. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:326-327.
12. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982;89:700-711.
13. Rodrigues MM, Rowden G, Hackette J, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci. 1981;21:759-765.
14. Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol. 1980;74:77-80.
15. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1:143-173.
16. Stuart PM, Griffith TS, Usui N. Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
17. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation. 1997;64:1107-1111.
18. Larkin DFK, Takano T, Standfield SD, Williams KA. Experimental orthotopic corneal xenotransplantation in the rat: mechanisms of graft rejection. Transplantation. 1995;60:491-497.
19. Ross JR, Howell DN. Sanfilippo FP. Characteristic of corneal xenograft rejection in a discordant species combination. Invest Ophthalmol Vis Sci. 1993;34:2469-2476.
20. Tanaka K, Streilein JW. Immunobiology of xenogeneic cornea grafts in mouse eyes. II. Immunogenicity of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes. Transplantation. 2000;69:616-623.
21. Yamagami S, Isobe M, Yamagami H, Hori J, Tsuru T. Mechanism of concordant corneal xenograft rejection in mice. Transplantation. 1997;64:42-48.
22. Dernouchamps JP. The proteins of the aqueous humor. Doc Ophthalmol. 1982;53:193-248.
23. Lass JH, Walter EI, Burris TE, et al. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci. 1990;31:1136-1148.
24. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci. 1993;34:3579-3584.
25. + cells. Transplantation Proc. 1995;27:260-261.
26. + T cells. J Exp Med. 1989;170:991-996.
27. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
28. Pleyer U, Milani JK, Dukes A, et al. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci. 1995;36:52-61.
29. + T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci. 1999;40:2614-2621.
30. Sano Y, Streilein JW, Ksander BR. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway." Transplantation. 1999;68: 963-970.
31. She S-C, Moticka EJ, Feder J. Prolonged survival of xenogeneic corneal grafts following anterior chamber injection of xenogeneic lymphocytes [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1992; 33(4):832. Abstract nr 700.